Eezy Oyj
EEZY PLC -- MANAGERS TRANSACTIONS -- 23 MARCH 2021 AT 10:32
Eezy Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Tapio Pajuharju
Position: Member of the Board/Deputy member
Issuer: Eezy OYJ
LEI: 743700ZKOMTB7X00OW54
Notification type: INITIAL NOTIFICATION
Reference number: 743700ZKOMTB7X00OW54_20210322174305_3
____________________________________________
Transaction date: 2021-03-22
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI4000322326
Nature of the transaction: ACQUISITION
Transaction details
(1): Volume: 3,433 Unit price: 5 EUR
Aggregated transactions
(1): Volume: 3,433 Volume weighted average price: 5 EUR
Additional information:
Hannu Nyman, CFO, tel. +358 (0)50 306 9913, hannu.nyman@eezy.fi
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ALK Abello19.12.2025 22:46:46 CET | Press release
Major shareholder announcement
ALK Abello19.12.2025 22:46:46 CET | Pressemeddelelse
Storaktionærmeddelelse
Zealand Pharma19.12.2025 22:00:00 CET | Press release
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Boehringer Ingelheim Limited19.12.2025 21:10:00 CET | Press release
U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults
Novartis Pharma AG19.12.2025 20:30:06 CET | Press release
Novartis and US government reach agreement on lowering drug prices in the US
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
